CytoImmune is committed to finding a cure for cancer. We are developing novel engineered Natural Killer (NK) cell therapies targeting solid and liquid tumors
Proud of our engineering and facilities teams @CytoImmune When Fiona hit, all backup systems engaged with no hitch. Site fully functional. Switched to local PR power yesterday. Standing with our neighbors in the west and south.
#CellsCreateHope#PuertoRicoStrong#FIONA2022
The CytoImmune team on #EarthDay2022 at our facility in Toa Baja, Puerto RIco where we are making strides to #InvestInOurPlanet by making green manuf'ng of our cells a priority. This is the team bringing the NK cell to patients in need
#WorldEarthDay2022#ClimateAction
Tonight was it @CytoImmune. Tonight we are a GMP facility and so proud. We are growing - our facility passed qualification and we are moving to our GMP runs for the next IND. Cancer is our foe and the NK cell is our ammo.
This is the team
#Immunotherapy#CellsCreateHope
Our recently published PNAS study demonstrates the 3rd signaling pathway that keeps the tumor-reactive NK cell "in character" in the TME. Further, these findings define a potential patient selection strategy in the clinic
#CellsCreateHope#Immunotherapy
https://t.co/rkVAdstdRo
TRACK-CAR-NK therapy in Pancreatic Ca. Preclinical data showing optimal PK/PD of our cells, their potency and trafficking in solid tumor models as well as extended survival with multiple doses of frozen and thawed CAR-NK
#CellsCreateHope#Immunotherapy
https://t.co/P4tsapBJTh
This is the manufacturing team at CytoImmune. Making our NK cells happen for patients. Engineering and Shakedown runs, check. GMP runs coming up soon ... racing to that IND.
#CellsCreateHope#Immunotherapy
Latin America is at the cutting edge of new developments in health technology and cures for cancer. Our science is disruptive in the NK space and our team in Puerto Rico π΅π· is second to none. Iβm honored to lead this team @CytoImmune#LetsDoThis#immunotherapy#CellsCreateHope
Our first town hall with our CEO Christina @coughlin582 today. We discussed the @Cytoimmune strategic focus, transition to Phase 1. We started with why today #StartWithWhy and how our #CellsCreateHope
We concluded with our annual Thanksgiving celebration
Our fantastic Quality group at @CytoImmune taking care of all aspects of manufacturing and our clinical programs. Quality is a full 20% of our staff at CytoImmune. Meeting today in Puerto Rico with our new CEO Christina @coughlin582#NKCells#QualityMatters#CellTherapy
The CytoImmune manufacturing facility in sunny Puerto Rico is delivering the first runs of our engineered NK cells only 10 months after construction started. We are on our way! #immunotherapy#cancer#NKCells